10 10A - The Michigan Daily - Thursday, November 14, 2002 Blue wary of matchup with winless 'Cats MEN'S SOCCER 1EN CONFERENCE STATE COLLEGE By Gennaro Filice Daily Sports Writer AP PHOTO/Daily The Mississippi State offensive line might not be the only group putting the hurt on Alabama after the NCAA reopens its investigation into the Crimson Tide. NCAA wants another look at Crimson Tide BIRMINGHAM, Ala. (AP) - A recruiting scandal that landed Alaba- ma's football program on probation could go before the NCAA again based on new information made public in court last week. Tom Yeager, chairman of the infractions committee, said yesterday the NCAA is evaluating claims revealed during a hearing in which a former high school coach pleaded guilty to accepting $150,000 to steer a prized recruit to Alabama. The plea directly implicated two former Alabama coaches. The enforcement staff could either shelve the matter or send it to the com- mittee for further review, Yeager said in a telephone interview with The Associ- ated Press. No decision has been made. Yeager declined comment on whether additional penalties were pos- sible against Alabama, which in Febru- ary was hit with scholarship limitations, a two-year bowl ban and five years of probation. Yeager said the staff would pass along only information that was sub- stantially different from what the com- mittee previously heard. But it's not uncommon for the committee to receive reports about infractions it pre- viously considered, he said. "In some cases it's a lingering chain of events that can occur," Yeager said. University counsel Stan Murphy referred a call to university spokesman Larry White, who declined comment. An NCAA investigator was in court last week in Memphis, Tenn., as for- mer Trezevant High School coach Lynn Lang pleaded guilty to a federal racketeering charge and agreed to cooperate with investigators. A former Lang assistant, Milton Kirk, previously pleaded guilty. With his plea, Lang agreed to the government's contention that he took money from Logan Young, a wealthy Memphis businessman and longtime Alabama booster, to steer defensive lineman Albert Means toward Alaba- ma. Young is a longtime friend of Alabama athletic director Mal Moore. Lang said he was referred to Young by Ivy Williams, a former Alabama assistant, and that he discussed the deal with Ronnie Cottrell, a former Alaba- ma recruiting coordinator. Assistant U.S. Attorney Fred God- win also said in court that Williams suggested that Lang arrange for some- one to take the place of Means during a college entrance test. The disclosures appeared to be at odds with the NCAA's previous deci- sion in the Alabama case since the sanctioning body did not directly implicate the Alabama coaching staff in any major recruiting violations. Alabama was not cited for lack of institutional control, a violation that could have brought more severe sanc- tions, possibly even the "death penal- ty," which shuts down a program for at least one season. The NCAA cleared Williams of lying to an NCAA investigator about the scandal after initially accusing him of providing false information about the case. Williams has repeatedly denied any wrongdoing. The Northwestern men's soccer team finished the season in the Big Ten cel- lar with a 0-6 mark in j . conference play. In these SfTA:iTE COLLEGE six games, the Wildcats were outscored by a co m- Wh:Mcigan (3-3 Big bined mark of 12-1. On Ten, 9.6.2 overall) vs. Oct.27,Nortwesern Northwestern (-6, 8&11) When: 4 p.m. today suffered its worst loss of Latest: The Wolverines the season in a 5-0 shel- open the Big Ten Tourna- lacking by Michigan. So, ment as the No.2 seed,but what does Michigan are expecting a battle from coach Steve Burns think winless Northwestern. of this Wildcats squad, which the Wolverines face off against today in the first round of the Big Ten Tournament? "They're like a caged animal," said Burns. "They're very dangerous." Today, the second-seeded Wolverines go to battle against the seventh-seeded Wildcats, and although Northwestern served as the Big Ten's punching bag in the regular season, Burns refuses to look ahead to a potential second-round matchup against either Ohio State or Michigan State. "We don't know what they're going to put togeth- er," Burns said. "I think that they could put together a great game and play with a ferocity which we just haven't seen from them, and they could catch us off guard. So a lot of the training we are doing right now is psychological, in the sense that we don't want our players looking past this game because this is the Three's of a kind In just the program's third year, Steve Burns' team is in position to win its first conference crowd. Michigan was just 3-3 in Big Ten play. But thanks to a very balanced conference, and several teams also with 3-3 records, the Wolverines are the No. 2 seed in this year's Big Ten Tournament because of goal differential. BIG TEN PTs. GF GA 1. Indiana 6-0-0 18 19 5 2. Michigan 3-3-0 9 11 7 3. Ohio State 3-3-0 9 8 7 4. Penn State 3-3-0 9 5 5 5. Wisconsin 3-3-0 9 8 11 6. Michigan State 3-3-0 9 7 12 7. Northwestern 0-6-0 0 1 12 JASON COOPER/Daily Knox Cameron and the rest of the Michigan soccer team are hoping that Northwestern doesn't grab its first conference win of the year at the Wolverines' expense in the Big Ten Tournament's first round today. biggest game right here for us." The Wolverines will attempt to repeat their second best offensive output of the year (the aforementioned 5-0 drubbing), a final score that Burns says may have been a bit deceiving. "We had a very good game against Northwest- ern," Burns said. "Four of the five goals we scored in that game were 'nice' goals. But, 'nice' goals don't come all the time. So, I think you could say that we were in form and we finished well that day, but it certainly could have been a much tighter score." Although the game may have been closer than the score indicated, Burns expects the Wildcats to incor- porate a different game plan than the "toe-to-toe" attack that they utilized Oct. 27. "If I were their coach, I would look to pack it in' Burns said. "I would look to keep it a low scoring affair, and I think we'll see that." The Wildcats are paced by freshman scoring machine Tito Lara. The forward led Northwestern with 13 points on six goals and one assist. In goal, Northwestern boasts a solid keeper in J.D. Martin, who has produced a 1.29 goals-against average. Although these two Wildcats could present Michi- gan with a challenge, the player who may hinder the Wolverines' production the most may not even be on the Northwestern roster. Michigan will have to play through the Big Ten tournament without its second-leading point scorer, Knox Cameron, who is currently representing the United States on the Under-20 national team. "What we've learned so far (during Cameron's absence) is that you can think about how you're going to play without one of your better players on the field, but until you actually get some games, that may not be true, Burns said. But Burns does believe he has made leeway in replacing Cameron. "The two scenarios that we thought we'd use with- out Knox Cameron have both proved to be false," Burns said. "We're now on our third, and we think we've figured it out in terms of Ian Hirschfield and Karl Lopata at attacking-mid positions." If Michigan's adjustments are successful, and it beats Northwestern, it will face one of two archrivals tomorrow: Both teams, Ohio State and Michigan State, finished tied with the Wolverines for second place in the Big Ten regular season. The prospective matchup against either team excites Burns. "Both of these teams would give us a great game, and we would look forward to that if we can get past Northwestern," Burns said. I I or It's in with the old for Giants: Alou takes over I SAN FRANCISCO (AP) - To handle their veteran team, the San Francisco Giants turned to an old pro: Felipe Alou. The 67-year- old Alou becameo the oldest manag- er to take over a club since Casey Stengel four decades ago. Not that Alou was worrying about his age after the National LeagueA champions hired him yesterday to replace Dusty Baker. "I'm a soldier of this game," said Alou, who played for San Francisco IL Ciotr e tve iInection medroxyprogesterone acetate injectable suspension 3'irtk control you tkiryc agoutt jus-t iI- x a year it v + DEPO-PROVERAI Contraceptive Injection (medroxyprogesterone acetate injectable suspension. USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is liven as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I3 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely or pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERPA Contraceptive Injection depends on following the recommended dosage schedule exactly (see "How often du I get my shotsof DEPO-PROVEA Contraceptive Injection?"). To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual period; ONLY within the first S days after childbirth if not breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth, It is a long-term injectable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need in order to decide which contraceptive method is the right choice for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods, It gives both the lowest expected rate of pregnanty the rate expected in women who use each method exactly as it should be used)and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use " if you have had cancer of the breast " if you have had a stroke " if you have or have had blood clots (phlebitis) in your legs - if you have problems with your liver or liver disease - if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor prescnbes DEPO-PROVERA. It is important to tell your health-care provider if you have any of the following: * a family history of breast cancer " an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples " kidney disease - irregular or scanty menstrual periods " high blood pressure " migraine headaches "asthma Sepilepsy (convulsions or seizures) "diabetes or a family history of diabetes " a history of depression " if you are taking any prescnption or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection: about two thirds of those who become pregnant will do so in about 12 months: about 83% of those who become pregnant will do so in about 15 months; and about 93% of those who become regnant will do so in about I 8 months after their last injection. The length of time you use O-PROVERA has no effect on how ong it takes you to become pregnant after you stop using it What are the risks of using DEPO-PROYERA Contraceptive Injection? I .rregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle. During the first year of using DEPO-PROVERA. you might have one or more of the following changes: irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA; and if this happens, you should see your health-care provider right away. With continued use of DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely. In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the 6.Otlter Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section. What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot in the lung) e sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke) - severe pain or swelling in the calf (indicating a possible clot in the leg) " unusually heavy vaginal bleeding * severe pain or tenderness in the lower abdominal area p ersistent pain, pus, or bleeding at the injection site What are the possible side effects of DEPO-PROVERA contraceptive Injection? I.Weight Goin You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You may continue to gain weight after the first year Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an average total of 3.8 pounds over those 4 years, or approximately 3.5 pounds per year Women who continued for 6 years gained an average total of I 6.5 pounds over those 6 years, or approximately 2.75 pounds per year 2.Qdner Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irrtation, breast swelling and tenderness, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flashes, and joint pain. Other problems were reported by very few of the women in the clinical tnials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility deep vein thrombosis, pulmonary embolus. breast cancer; or cervical cancer. If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider. Should any recautions be followed during use of DEPO-PROVERA Contraceptive Injection? I.Missed Periods Dunng the time you are using DEPO-PROVERA for contraception, you may skip a period, or your penods may stop completely If you have been receiving your DEPO-PROVEPA injections regularly every 3 months (13 weeks), then you are probably not pregnant However; if you think that you may be pregnant, see your health-care provider 2.Loborotory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVEPA for contraception. Certain blood tests are affected by hormones such as in the 1950s and '60s. "The matter of energy and enthusiasm, some- body else is going to have to evalu- ate that." Stengel was 71 when the New York Mets lured him out of retire- ment in October 1961 to manage them the next year in their first sea- son, according to the Elias Sports Bureau and the Hall of Fame. It's been a good week for older coaches. On Tuesday, the NBA's Memphis Grizzlies hired Hubie Brown, 69. Alou, the former Montreal man- ager and a bench coach for Detroit last season, was excited to return to the Giants. He inherits a team led by five-time MVP Barry Bonds. "I'm going back home to where I started and, hopefully, I'm going to end it right there," he said. Alou agreed to a three-year con- tract and becomes the oldest man- ager in the major leagues. He was 691-717 in 10 seasons managing the Expos. The popular Baker did not have his contract renewed by the Giants after coming within six outs of the World Series championship. Baker is talking with the Chicago Cubs about becoming their manager. Alou's son Moises plays for the Cubs. "I was happily surprised," Moi- ses said. "For him to get a job with a team like the Giants is awesome." Alou played for the Giants from 1958-63 as part of a solid 17-sea- son major league career in which he hit .286 with 206 homers and 852 RBIs. He also spent 1970 and part of 1971 in the Bay area playing for the Oakland Athletics. On the Giants, he joined brothers Matty and Jesus in an all-Alou out- field in some games. That's one of the highlights of his playing days in San Francisco, along with a string of nine consec- utive hits. "When I received the first notice that I might be the guy, or the club Lowest Method Expected Typical DEPO-PROVERA 03 0.3 Implants (Norplant) 0.2 0.2° Female sterilization 0.2 0.4 Male Sterilization 01 0.15